$ENZN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ENZON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ENZON PHARMACEUTICALS, INC.. Get notifications about new insider transactions in ENZON PHARMACEUTICALS, INC. for free.
Page: < prev 1 ... 2 3 4 5 6 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 20 2007 | ENZN | ENZON PHARMACEUTIC ... | Highbridge International LLC | 10% Owner | Sell | J | 8.72 | 8,700 | 75,864 | 56,176 | 64.9 K to 56.2 K (-13.41 %) |
Feb 20 2007 | ENZN | ENZON PHARMACEUTIC ... | Highbridge International LLC | 10% Owner | Sell | J | 8.71 | 4,034 | 35,136 | 64,876 | 68.9 K to 64.9 K (-5.85 %) |
Feb 20 2007 | ENZN | ENZON PHARMACEUTIC ... | Highbridge International LLC | 10% Owner | Buy | P | 8.71 | 4,034 | 35,136 | 68,910 | 64.9 K to 68.9 K (+6.22 %) |
Feb 20 2007 | ENZN | ENZON PHARMACEUTIC ... | Highbridge International LLC | 10% Owner | Buy | P | 8.72 | 8,700 | 75,864 | 64,876 | 56.2 K to 64.9 K (+15.49 %) |
Feb 20 2007 | ENZN | ENZON PHARMACEUTIC ... | Highbridge International LLC | 10% Owner | Buy | P | 8.73 | 9,065 | 79,137 | 56,176 | 47.1 K to 56.2 K (+19.24 %) |
Feb 20 2007 | ENZN | ENZON PHARMACEUTIC ... | Highbridge International LLC | 10% Owner | Buy | P | 8.74 | 8,743 | 76,414 | 47,111 | 38.4 K to 47.1 K (+22.79 %) |
Feb 20 2007 | ENZN | ENZON PHARMACEUTIC ... | Highbridge International LLC | 10% Owner | Buy | P | 8.75 | 8,368 | 73,220 | 38,368 | 30 K to 38.4 K (+27.89 %) |
Feb 20 2007 | ENZN | ENZON PHARMACEUTIC ... | Highbridge International LLC | 10% Owner | Buy | P | 8.67 | 30,000 | 260,100 | 30,000 | 0 to 30 K |
Jan 19 2007 | ENZN | ENZON PHARMACEUTIC ... | BUCHALTER JEFFREY H | Chairman, CEO & Pre ... | Option Exercise | A | 8.59 | 850,000 | 7,301,500 | 850,000 | |
Jan 19 2007 | ENZN | ENZON PHARMACEUTIC ... | BUCHALTER JEFFREY H | Chairman, CEO & Pre ... | Grant | A | 0.00 | 100,000 | 0 | 198,234 | 98.2 K to 198.2 K (+101.80 %) |
Jan 19 2007 | ENZN | ENZON PHARMACEUTIC ... | del Campo Ralph | EVP, Technical Oper ... | Option Exercise | A | 8.59 | 300,000 | 2,577,000 | 300,000 | |
Jan 19 2007 | ENZN | ENZON PHARMACEUTIC ... | del Campo Ralph | EVP, Technical Oper ... | Grant | A | 0.00 | 25,000 | 0 | 57,601 | 32.6 K to 57.6 K (+76.68 %) |
Jan 19 2007 | ENZN | ENZON PHARMACEUTIC ... | Davit Paul Stephen | EVP, Human Resource ... | Option Exercise | A | 8.59 | 100,000 | 859,000 | 100,000 | |
Jan 19 2007 | ENZN | ENZON PHARMACEUTIC ... | HORAK IVAN D | EVP, R&D & Ch. Scie ... | Option Exercise | A | 8.59 | 300,000 | 2,577,000 | 300,000 | |
Jan 19 2007 | ENZN | ENZON PHARMACEUTIC ... | HORAK IVAN D | EVP, R&D & Ch. Scie ... | Grant | A | 0.00 | 25,000 | 0 | 33,500 | 8.5 K to 33.5 K (+294.12 %) |
Jan 04 2007 | ENZN | ENZON PHARMACEUTIC ... | SALISBURY ROBERT C | Director | Option Exercise | A | 8.19 | 15,000 | 122,850 | 15,000 | |
Jan 19 2007 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | EVP, Finance & CFO | Option Exercise | A | 8.59 | 300,000 | 2,577,000 | 300,000 | |
Jan 19 2007 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | EVP, Finance & CFO | Grant | A | 0.00 | 25,000 | 0 | 51,000 | 26 K to 51 K (+96.15 %) |
Jan 04 2007 | ENZN | ENZON PHARMACEUTIC ... | Renfro Phillip M | Director | Option Exercise | A | 8.19 | 15,000 | 122,850 | 15,000 | |
Jan 04 2007 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Option Exercise | A | 8.19 | 15,000 | 122,850 | 15,000 | |
Jan 04 2007 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Option Exercise | M | 2.94 | 40,000 | 117,500 | 0 | |
Jan 04 2007 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Buy | M | 2.94 | 40,000 | 117,500 | 83,715 | 43.7 K to 83.7 K (+91.50 %) |
Jan 04 2007 | ENZN | ENZON PHARMACEUTIC ... | MICATI VICTOR P | Director | Option Exercise | A | 8.19 | 15,000 | 122,850 | 15,000 | |
Jan 04 2007 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Option Exercise | A | 8.19 | 15,000 | 122,850 | 15,000 | |
Jan 04 2007 | ENZN | ENZON PHARMACEUTIC ... | ANDO GORAN | Director | Option Exercise | A | 8.19 | 15,000 | 122,850 | 15,000 | |
Dec 13 2006 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Option Exercise | M | 2.94 | 30,000 | 88,125 | 0 | |
Dec 13 2006 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Sell | S | 8.23 | 30,000 | 246,810 | 12,516 | 42.5 K to 12.5 K (-70.56 %) |
Dec 13 2006 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Buy | M | 2.94 | 30,000 | 88,125 | 42,516 | 12.5 K to 42.5 K (+239.69 %) |
Jul 05 2006 | ENZN | ENZON PHARMACEUTIC ... | SALISBURY ROBERT C | Director | Option Exercise | A | 0.00 | 3,316 | 0 | 3,316 | |
Jul 05 2006 | ENZN | ENZON PHARMACEUTIC ... | SALISBURY ROBERT C | Director | Option Exercise | M | 0.00 | 1,255 | 0 | 2,510 | |
Jul 05 2006 | ENZN | ENZON PHARMACEUTIC ... | SALISBURY ROBERT C | Director | Buy | M | 0.00 | 1,255 | 0 | 6,852 | 5.6 K to 6.9 K (+22.42 %) |
Jul 05 2006 | ENZN | ENZON PHARMACEUTIC ... | MICATI VICTOR P | Director | Option Exercise | A | 0.00 | 3,316 | 0 | 3,316 | |
Jul 05 2006 | ENZN | ENZON PHARMACEUTIC ... | MICATI VICTOR P | Director | Option Exercise | M | 0.00 | 1,255 | 0 | 2,510 | |
Jul 05 2006 | ENZN | ENZON PHARMACEUTIC ... | MICATI VICTOR P | Director | Buy | M | 0.00 | 1,255 | 0 | 2,821 | 1.6 K to 2.8 K (+80.14 %) |
Jul 05 2006 | ENZN | ENZON PHARMACEUTIC ... | Renfro Phillip M | Director | Option Exercise | A | 0.00 | 3,316 | 0 | 3,316 | |
Jul 05 2006 | ENZN | ENZON PHARMACEUTIC ... | Renfro Phillip M | Director | Option Exercise | M | 0.00 | 1,255 | 0 | 2,510 | |
Jul 05 2006 | ENZN | ENZON PHARMACEUTIC ... | Renfro Phillip M | Director | Buy | M | 0.00 | 1,255 | 0 | 3,151 | 1.9 K to 3.2 K (+66.19 %) |
Jul 05 2006 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Option Exercise | A | 0.00 | 3,316 | 0 | 3,316 | |
Jul 05 2006 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Option Exercise | M | 0.00 | 1,255 | 0 | 2,510 | |
Jul 05 2006 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Buy | M | 0.00 | 1,255 | 0 | 43,715 | 42.5 K to 43.7 K (+2.96 %) |
Jul 05 2006 | ENZN | ENZON PHARMACEUTIC ... | ANDO GORAN | Director | Option Exercise | A | 0.00 | 3,316 | 0 | 3,316 | |
Jul 05 2006 | ENZN | ENZON PHARMACEUTIC ... | ANDO GORAN | Director | Option Exercise | M | 0.00 | 1,255 | 0 | 2,510 | |
Jul 05 2006 | ENZN | ENZON PHARMACEUTIC ... | ANDO GORAN | Director | Buy | M | 0.00 | 1,255 | 0 | 2,821 | 1.6 K to 2.8 K (+80.14 %) |
Jul 05 2006 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Option Exercise | A | 0.00 | 3,316 | 0 | 3,316 | |
Jul 05 2006 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Option Exercise | M | 0.00 | 1,255 | 0 | 2,510 | |
Jul 05 2006 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Buy | M | 0.00 | 1,255 | 0 | 12,516 | 11.3 K to 12.5 K (+11.14 %) |
May 19 2006 | ENZN | ENZON PHARMACEUTIC ... | BUCHALTER JEFFREY H | Chairman, CEO & Pre ... | Option Exercise | A | 7.40 | 436,000 | 3,226,400 | 436,000 | |
May 19 2006 | ENZN | ENZON PHARMACEUTIC ... | HORAK IVAN D | EVP-R&D & Chief Sci ... | Option Exercise | A | 7.40 | 145,700 | 1,078,180 | 145,700 | |
May 19 2006 | ENZN | ENZON PHARMACEUTIC ... | del Campo Ralph | EVP - Technical Ope ... | Option Exercise | A | 7.40 | 92,500 | 684,500 | 92,500 | |
May 19 2006 | ENZN | ENZON PHARMACEUTIC ... | Davit Paul Stephen | Exec. Vice Pres. HR | Option Exercise | A | 7.40 | 70,000 | 518,000 | 70,000 | |
May 19 2006 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Option Exercise | A | 7.40 | 122,700 | 907,980 | 122,700 | |
Apr 05 2006 | ENZN | ENZON PHARMACEUTIC ... | HORAK IVAN D | EVP-R&D & Chief Sci ... | Option Exercise | A | 8.04 | 66,200 | 532,248 | 66,200 | |
Apr 05 2006 | ENZN | ENZON PHARMACEUTIC ... | HORAK IVAN D | EVP-R&D & Chief Sci ... | Option Exercise | A | 8.04 | 122,900 | 988,116 | 122,900 | |
Apr 05 2006 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Option Exercise | A | 0.00 | 55,800 | 0 | 55,800 | |
Apr 05 2006 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Option Exercise | A | 8.04 | 103,500 | 832,140 | 103,500 | |
Apr 05 2006 | ENZN | ENZON PHARMACEUTIC ... | del Campo Ralph | EVP - Technical Ope ... | Option Exercise | A | 0.00 | 42,000 | 0 | 42,000 | |
Apr 05 2006 | ENZN | ENZON PHARMACEUTIC ... | del Campo Ralph | EVP - Technical Ope ... | Option Exercise | A | 8.04 | 78,000 | 627,120 | 78,000 | |
Apr 05 2006 | ENZN | ENZON PHARMACEUTIC ... | Davit Paul Stephen | Exec. Vice Pres. HR | Option Exercise | A | 0.00 | 31,900 | 0 | 31,900 | |
Apr 05 2006 | ENZN | ENZON PHARMACEUTIC ... | Davit Paul Stephen | Exec. Vice Pres. HR | Option Exercise | A | 8.04 | 59,200 | 475,968 | 59,200 | |
Apr 05 2006 | ENZN | ENZON PHARMACEUTIC ... | BUCHALTER JEFFREY H | Chairman, CEO & Pre ... | Option Exercise | A | 0.00 | 198,100 | 0 | 198,100 | |
Apr 05 2006 | ENZN | ENZON PHARMACEUTIC ... | BUCHALTER JEFFREY H | Chairman, CEO & Pre ... | Option Exercise | A | 8.04 | 367,900 | 2,957,916 | 367,900 | |
Mar 07 2006 | ENZN | ENZON PHARMACEUTIC ... | BUCHALTER JEFFREY H | Chairman, CEO & Pre ... | Buy | P | 6.88 | 6,500 | 44,720 | 98,234 | 91.7 K to 98.2 K (+7.09 %) |
Mar 07 2006 | ENZN | ENZON PHARMACEUTIC ... | BUCHALTER JEFFREY H | Chairman, CEO & Pre ... | Buy | P | 6.82 | 1,000 | 6,820 | 91,734 | 90.7 K to 91.7 K (+1.10 %) |
Mar 07 2006 | ENZN | ENZON PHARMACEUTIC ... | BUCHALTER JEFFREY H | Chairman, CEO & Pre ... | Buy | P | 6.81 | 2,500 | 17,025 | 90,734 | 88.2 K to 90.7 K (+2.83 %) |
Mar 07 2006 | ENZN | ENZON PHARMACEUTIC ... | HORAK IVAN D | EVP-R&D & Chief Sci ... | Buy | P | 6.87 | 200 | 1,374 | 8,500 | 8.3 K to 8.5 K (+2.41 %) |
Mar 07 2006 | ENZN | ENZON PHARMACEUTIC ... | HORAK IVAN D | EVP-R&D & Chief Sci ... | Buy | P | 6.88 | 1,300 | 8,939 | 8,300 | 7 K to 8.3 K (+18.57 %) |
Mar 07 2006 | ENZN | ENZON PHARMACEUTIC ... | HORAK IVAN D | EVP-R&D & Chief Sci ... | Buy | P | 6.87 | 500 | 3,434 | 7,000 | 6.5 K to 7 K (+7.69 %) |
Mar 07 2006 | ENZN | ENZON PHARMACEUTIC ... | HORAK IVAN D | EVP-R&D & Chief Sci ... | Buy | P | 6.86 | 1,000 | 6,858 | 6,500 | 5.5 K to 6.5 K (+18.18 %) |
Mar 07 2006 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Buy | P | 6.87 | 1,000 | 6,868 | 26,000 | 25 K to 26 K (+4.00 %) |
Jan 04 2006 | ENZN | ENZON PHARMACEUTIC ... | SALISBURY ROBERT C | Director | Option Exercise | A | 7.40 | 15,000 | 111,000 | 15,000 | |
Jan 04 2006 | ENZN | ENZON PHARMACEUTIC ... | Renfro Phillip M | Director | Option Exercise | A | 7.40 | 15,000 | 111,000 | 15,000 | |
Jan 04 2006 | ENZN | ENZON PHARMACEUTIC ... | MICATI VICTOR P | Director | Option Exercise | A | 7.40 | 15,000 | 111,000 | 15,000 | |
Jan 04 2006 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Option Exercise | A | 7.40 | 15,000 | 111,000 | 15,000 | |
Jan 04 2006 | ENZN | ENZON PHARMACEUTIC ... | DIXON ROSINA B | Director | Option Exercise | A | 7.40 | 15,000 | 111,000 | 15,000 | |
Jan 04 2006 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Option Exercise | A | 7.40 | 15,000 | 111,000 | 15,000 | |
Jan 04 2006 | ENZN | ENZON PHARMACEUTIC ... | ANDO GORAN | Director | Option Exercise | A | 7.40 | 15,000 | 111,000 | 15,000 | |
Nov 28 2005 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Nov 28 2005 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec VP Finance, CF ... | Option Exercise | A | 6.97 | 50,000 | 348,500 | 50,000 | |
Nov 28 2005 | ENZN | ENZON PHARMACEUTIC ... | HORAK IVAN D | EVP-R&D & Chief Sci ... | Option Exercise | A | 0.00 | 7,500 | 0 | 7,500 | |
Nov 28 2005 | ENZN | ENZON PHARMACEUTIC ... | HORAK IVAN D | EVP-R&D & Chief Sci ... | Option Exercise | A | 6.97 | 35,000 | 243,950 | 35,000 | |
Nov 28 2005 | ENZN | ENZON PHARMACEUTIC ... | Davit Paul Stephen | Exec. Vice Pres. HR | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Nov 28 2005 | ENZN | ENZON PHARMACEUTIC ... | Davit Paul Stephen | Exec. Vice Pres. HR | Option Exercise | A | 6.97 | 50,000 | 348,500 | 50,000 | |
Nov 28 2005 | ENZN | ENZON PHARMACEUTIC ... | delcampo ralph | EVP - Technical Ope ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Nov 28 2005 | ENZN | ENZON PHARMACEUTIC ... | delcampo ralph | EVP - Technical Ope ... | Option Exercise | A | 6.97 | 50,000 | 348,500 | 50,000 | |
Nov 28 2005 | ENZN | ENZON PHARMACEUTIC ... | BUCHALTER JEFFREY H | Chairman, CEO & Pre ... | Option Exercise | A | 0.00 | 120,000 | 0 | 120,000 | |
Nov 28 2005 | ENZN | ENZON PHARMACEUTIC ... | BUCHALTER JEFFREY H | Chairman, CEO & Pre ... | Option Exercise | A | 6.97 | 300,000 | 2,091,000 | 300,000 | |
Oct 05 2005 | ENZN | ENZON PHARMACEUTIC ... | HORAK IVAN D | EVP-R&D & Chief Sci ... | Buy | P | 7.18 | 5,500 | 39,490 | 5,500 | 0 to 5.5 K |
Oct 11 2005 | ENZN | ENZON PHARMACEUTIC ... | Davit Paul Stephen | Exec. Vice Pres. HR | Buy | P | 7.03 | 6,500 | 45,695 | 39,300 | 32.8 K to 39.3 K (+19.82 %) |
Sep 08 2005 | ENZN | ENZON PHARMACEUTIC ... | SALISBURY ROBERT C | Director | Option Exercise | A | 0.00 | 3,765 | 0 | 3,765 | |
Sep 08 2005 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Option Exercise | A | 0.00 | 3,765 | 0 | 3,765 | |
Sep 08 2005 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Option Exercise | A | 13.77 | 15,000 | 206,550 | 15,000 | |
Sep 08 2005 | ENZN | ENZON PHARMACEUTIC ... | DIXON ROSINA B | Director | Option Exercise | A | 0.00 | 3,765 | 0 | 3,765 | |
Sep 08 2005 | ENZN | ENZON PHARMACEUTIC ... | DIXON ROSINA B | Director | Option Exercise | A | 13.77 | 15,000 | 206,550 | 15,000 | |
Sep 08 2005 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Option Exercise | A | 0.00 | 3,765 | 0 | 3,765 | |
Sep 08 2005 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Option Exercise | A | 13.77 | 15,000 | 206,550 | 15,000 | |
Sep 08 2005 | ENZN | ENZON PHARMACEUTIC ... | MICATI VICTOR P | Director | Option Exercise | A | 0.00 | 3,765 | 0 | 3,765 | |
Sep 08 2005 | ENZN | ENZON PHARMACEUTIC ... | MICATI VICTOR P | Director | Option Exercise | A | 13.77 | 15,000 | 206,550 | 15,000 | |
Sep 08 2005 | ENZN | ENZON PHARMACEUTIC ... | Renfro Phillip M | Director | Option Exercise | A | 0.00 | 3,765 | 0 | 3,765 | |
Sep 08 2005 | ENZN | ENZON PHARMACEUTIC ... | ANDO GORAN | Director | Option Exercise | A | 0.00 | 3,765 | 0 | 3,765 | |
Sep 08 2005 | ENZN | ENZON PHARMACEUTIC ... | ANDO GORAN | Director | Option Exercise | A | 13.77 | 15,000 | 206,550 | 15,000 | |
Sep 07 2005 | ENZN | ENZON PHARMACEUTIC ... | HORAK IVAN D | EVP-R&D & Chief Sci ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Sep 07 2005 | ENZN | ENZON PHARMACEUTIC ... | HORAK IVAN D | EVP-R&D & Chief Sci ... | Option Exercise | A | 7.14 | 200,000 | 1,428,000 | 200,000 | |
Jun 14 2005 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Exec. V.P. - Financ ... | Option Exercise | A | 5.73 | 50,000 | 286,500 | 50,000 | |
Jun 10 2005 | ENZN | ENZON PHARMACEUTIC ... | BUCHALTER JEFFREY H | Chief Executive Off ... | Buy | P | 5.75 | 10,000 | 57,500 | 88,234 | 78.2 K to 88.2 K (+12.78 %) |
May 16 2005 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Executive Vice Pres ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
May 16 2005 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Executive Vice Pres ... | Option Exercise | A | 6.95 | 50,000 | 347,500 | 50,000 | |
May 16 2005 | ENZN | ENZON PHARMACEUTIC ... | Davit Paul Stephen | EVP, Human Resource ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
May 16 2005 | ENZN | ENZON PHARMACEUTIC ... | Davit Paul Stephen | EVP, Human Resource ... | Option Exercise | A | 6.95 | 50,000 | 347,500 | 50,000 | |
May 16 2005 | ENZN | ENZON PHARMACEUTIC ... | delcampo ralph | EVP, Technical Oper ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
May 16 2005 | ENZN | ENZON PHARMACEUTIC ... | delcampo ralph | EVP, Technical Oper ... | Option Exercise | A | 6.95 | 50,000 | 347,500 | 50,000 | |
May 16 2005 | ENZN | ENZON PHARMACEUTIC ... | SALISBURY ROBERT C | Director | Option Exercise | A | 6.95 | 20,000 | 139,000 | 20,000 | |
May 16 2005 | ENZN | ENZON PHARMACEUTIC ... | SALISBURY ROBERT C | Director | Grant | A | 0.00 | 3,597 | 0 | 5,597 | 2 K to 5.6 K (+179.85 %) |
May 16 2005 | ENZN | ENZON PHARMACEUTIC ... | BUCHALTER JEFFREY H | Chief Executive Off ... | Option Exercise | A | 6.95 | 750,000 | 5,212,500 | 750,000 | |
Feb 02 2005 | ENZN | ENZON PHARMACEUTIC ... | DIXON ROSINA B | Director | Gift | G | 0.00 | 825 | 0 | 55,433 | 56.3 K to 55.4 K (-1.47 %) |
Jan 07 2005 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Executive Vice Pres ... | Option Exercise | A | 13.08 | 125,000 | 1,635,000 | 125,000 | |
Jan 07 2005 | ENZN | ENZON PHARMACEUTIC ... | TOOMAN CRAIG A | Executive Vice Pres ... | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
Jan 06 2005 | ENZN | ENZON PHARMACEUTIC ... | Renfro Phillip M | Director | Option Exercise | A | 13.18 | 20,000 | 263,600 | 20,000 | |
Jan 06 2005 | ENZN | ENZON PHARMACEUTIC ... | Renfro Phillip M | Director | Grant | A | 0.00 | 1,896 | 0 | 1,896 | 0 to 1.9 K |
Dec 27 2004 | ENZN | ENZON PHARMACEUTIC ... | BUCHALTER JEFFREY H | Chief Executive Off ... | Option Exercise | A | 13.54 | 725,000 | 9,816,500 | 725,000 | |
Dec 27 2004 | ENZN | ENZON PHARMACEUTIC ... | BUCHALTER JEFFREY H | Chief Executive Off ... | Grant | A | 0.00 | 75,000 | 0 | 75,000 | 0 to 75 K |
Nov 15 2004 | ENZN | ENZON PHARMACEUTIC ... | MICATI VICTOR P | Director | Option Exercise | A | 15.96 | 20,000 | 319,200 | 20,000 | |
Nov 15 2004 | ENZN | ENZON PHARMACEUTIC ... | MICATI VICTOR P | Director | Grant | A | 0.00 | 1,566 | 0 | 1,566 | 0 to 1.6 K |
Nov 15 2004 | ENZN | ENZON PHARMACEUTIC ... | MICATI VICTOR P | Director | Option Exercise | A | 15.96 | 20,000 | 319,200 | 20,000 | |
Nov 15 2004 | ENZN | ENZON PHARMACEUTIC ... | MICATI VICTOR P | Director | Grant | A | 0.00 | 1,566 | 0 | 1,566 | 0 to 1.6 K |
Nov 15 2004 | ENZN | ENZON PHARMACEUTIC ... | ANDO GORAN | Director | Option Exercise | A | 15.96 | 20,000 | 319,200 | 20,000 | |
Nov 15 2004 | ENZN | ENZON PHARMACEUTIC ... | ANDO GORAN | Director | Grant | A | 0.00 | 1,566 | 0 | 1,566 | 0 to 1.6 K |
Sep 29 2004 | ENZN | ENZON PHARMACEUTIC ... | BUCHALTER JEFFREY H | Director | Option Exercise | A | 15.46 | 40,000 | 618,400 | 40,000 | |
Sep 29 2004 | ENZN | ENZON PHARMACEUTIC ... | BUCHALTER JEFFREY H | Director | Grant | A | 0.00 | 3,234 | 0 | 3,234 | 0 to 3.2 K |
Jul 21 2004 | ENZN | ENZON PHARMACEUTIC ... | DIXON ROSINA B | Director | Option Exercise | M | 2.75 | 16,664 | 45,826 | 0 | |
Jul 21 2004 | ENZN | ENZON PHARMACEUTIC ... | DIXON ROSINA B | Director | Buy | M | 2.75 | 16,664 | 45,826 | 56,258 | 39.6 K to 56.3 K (+42.09 %) |
Jul 21 2004 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Option Exercise | M | 2.75 | 26,664 | 73,326 | 0 | |
Jul 21 2004 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Buy | M | 2.75 | 26,664 | 73,326 | 42,460 | 15.8 K to 42.5 K (+168.80 %) |
Jul 06 2004 | ENZN | ENZON PHARMACEUTIC ... | HIGGINS ARTHUR J | Director | Grant | A | 0.00 | 1,989 | 0 | 240,072 | 238.1 K to 240.1 K (+0.84 %) |
Jul 06 2004 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Grant | A | 0.00 | 1,989 | 0 | 11,261 | 9.3 K to 11.3 K (+21.45 %) |
Jul 06 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Grant | A | 0.00 | 1,989 | 0 | 3,268 | 1.3 K to 3.3 K (+155.51 %) |
Jul 06 2004 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Grant | A | 0.00 | 1,989 | 0 | 15,796 | 13.8 K to 15.8 K (+14.41 %) |
Jul 06 2004 | ENZN | ENZON PHARMACEUTIC ... | DIXON ROSINA B | Director | Grant | A | 0.00 | 1,989 | 0 | 39,594 | 37.6 K to 39.6 K (+5.29 %) |
Jun 15 2004 | ENZN | ENZON PHARMACEUTIC ... | ZUERBLIS KENNETH J | Executive V.P., Fin ... | Option Exercise | A | 12.27 | 25,000 | 306,750 | 25,000 | |
Jun 15 2004 | ENZN | ENZON PHARMACEUTIC ... | ZUERBLIS KENNETH J | Executive V.P., Fin ... | Grant | A | 0.00 | 27,500 | 0 | 35,330 | 7.8 K to 35.3 K (+351.21 %) |
Jun 15 2004 | ENZN | ENZON PHARMACEUTIC ... | ZUERBLIS KENNETH J | Executive V.P., Fin ... | Option Exercise | A | 12.27 | 25,000 | 306,750 | 25,000 | |
Jun 15 2004 | ENZN | ENZON PHARMACEUTIC ... | ZUERBLIS KENNETH J | Executive V.P., Fin ... | Grant | A | 0.00 | 27,500 | 0 | 35,330 | 7.8 K to 35.3 K (+351.21 %) |
May 19 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Option Exercise | M | 5.50 | 17,320 | 95,260 | 8,000 | |
May 19 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Sell | S | 14.27 | 1,630 | 23,260 | 1,279 | 2.9 K to 1.3 K (-56.03 %) |
May 19 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Sell | S | 14.31 | 400 | 5,724 | 2,909 | 3.3 K to 2.9 K (-12.09 %) |
May 19 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Sell | S | 14.32 | 2,300 | 32,936 | 3,309 | 5.6 K to 3.3 K (-41.01 %) |
May 19 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Sell | S | 14.35 | 1,600 | 22,960 | 5,609 | 7.2 K to 5.6 K (-22.19 %) |
May 19 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Sell | S | 14.37 | 1,000 | 14,370 | 7,209 | 8.2 K to 7.2 K (-12.18 %) |
May 19 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Sell | S | 14.38 | 755 | 10,857 | 8,209 | 9 K to 8.2 K (-8.42 %) |
May 19 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Sell | S | 14.39 | 6,981 | 100,457 | 8,964 | 15.9 K to 9 K (-43.78 %) |
May 19 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Sell | S | 14.41 | 800 | 11,528 | 15,945 | 16.7 K to 15.9 K (-4.78 %) |